Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.200
-0.050 (-4.00%)
At close: Sep 9, 2026, 4:00 PM EDT
1.230
+0.030 (2.50%)
Pre-market: Sep 10, 2026, 8:10 AM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $225.48 million as of September 9, 2026. Its market cap has decreased by -16.13% in one year.
Market Cap
225.48M
Enterprise Value
161.89M
1-Year Change
-16.13%
Ranking
Category
Stock Price
$1.20
ChartMarket Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $225.48M, a decrease of -91.27%. That is a compound annual growth rate of -55.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 225.48M | -25.88% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 243.06M |
| Compugen | 242.49M |
| Cellectis | 238.44M |
| Eledon Pharmaceuticals | 238.33M |
| NervGen Pharma | 235.47M |
| Adagene | 234.33M |
| Greenwich LifeSciences | 233.38M |
| Nkarta | 231.35M |